Antisense compounds, compositions and methods are provided for modulating the expression of CD81. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding CD81. Methods of using these compounds for modulation of CD81 expression and for treatment of diseases associated with expression of CD81 are provided.
申请公布号
WO03053342(A2)
申请公布日期
2003.07.03
申请号
WO2002US39182
申请日期
2002.12.09
申请人
ISIS PHARMACEUTICALS, INC.;GRAHAM, MARK, J.;DOBIE, KENNETH, W.